Searched for
DRUGMAKERS DEAL
US stocks: Dow closes at record on Mideast optimism; SpaceX, AMD drag NasdaqThe Dow Jones Industrial Average achieved an all-time high on Wednesday, driven by rising optimism over potential peace talks with Iran. Me...- 'No discussions' over AstraZeneca-Bristol Myers deal, senior source saysAstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was eve...
- School Assembly News Headlines, August 6, 2026: Top national, international, business, sports updates and thought of the daySchool Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...
- Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
- Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cutsPfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The co...
- US stocks: Dow closes at record high on Iran talks optimismUS stocks opened August with strong gains, pushing the Dow Industrials to a record closing high. Easing oil prices and Treasury yields supp...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
- US stocks: US market starts the month strong as Mideast deal hopes riseMajor US stock indexes opened higher on Monday. De-escalating Middle East tensions helped drag down crude oil prices. Investors are now pre...
- Global Market: European shares rise as easing Iran tensions lift sentiment; energy stocks slideAccording to Reuters, investor sentiment improved after Trump signalled a preference for diplomacy over immediate military action against I...
- Delhi court orders framing of charges in codeine syrup seizure caseA Delhi court ordered charges against Vipin Chawla for possessing over 4,300 kg of cough syrup. Police recovered 36,238 bottles of the bann...
- India says US trade talks helped it secure an export advantageIndia secured an advantage in United States tariffs due to ongoing trade negotiations. A significant portion of Indian exports remain exemp...
- Bain Capital acquires Vitabiotics: UK nutraceutical giant with India’s Meyer Organics valued at $850-900 millionPrivate equity firm Bain Capital has agreed to acquire UK-based nutraceutical company Vitabiotics, expanding its presence in the global wel...
- Bain Capital to accquire UK's leading vitamin company VitabioticsPrivate equity firm Bain Capital will acquire UK nutraceutical company Vitabiotics, including its India business Meyer Organics and African...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in IndiaIndia's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in ...
- Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley dealEli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...
- Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: ReportEli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge follow...
- AstraZeneca to license lung cancer drug from China's Dizal PharmaceuticalDizal Pharmaceutical shares rose significantly after announcing a major drug rights deal. AstraZeneca will pay $600 million upfront for glo...
- Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake saleBiocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the In...
- Mylan to sell up to $363 million stake in India's Biocon, term sheet showsMylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees ($363 million),...
Load More
